The Aurum Institute, in partnership with Market Access Africa and with funding from Unitaid, invites qualified and capable suppliers and manufacturers to submit proposals for the procurement and/or regulatory support of itraconazole for the treatment of histoplasmosis in Sub-Saharan Africa.
This Request for Proposals (RFP) is issued under the IMPAACT4HIV initiative to improve diagnosis and treatment of Advanced HIV Disease (AHD) in low- and middle-income countries (LMICs), specifically through increased access to antifungal treatment for histoplasmosis. The RFP includes two Lots supply and regulatory support and applicants may apply for one or both.
Deadline for Submission
All proposals must be submitted electronically to This email address is being protected from spambots. You need JavaScript enabled to view it. no later than 7 July 2025, 17:00 SAST, with the subject line: Request for Proposals – Itraconazole Procurement
Late submissions will not be accepted.
Queries
Questions regarding the RFP will be answered by email only within the 2 weeks following the posting of the RFP. It will not be possible to engage in telephone enquiries. All questions or clarifications must be submitted in writing to This email address is being protected from spambots. You need JavaScript enabled to view it. by 23 June 2025, 17:00 SAST
Responses will be consolidated and shared with all interested parties. Questions received after the deadline will not be addressed.
Download Documents
About IMPAACT4HIV
The Improved Access to AHD Care and Treatment for HIV (IMPAACT4HIV) project is a Unitaid-funded initiative led by the Aurum Institute, in partnership with Market Access Africa. The project aims to reduce mortality from Advanced HIV Disease by improving access to diagnostics and treatment including antifungal therapies through innovative, community- based, and country-owned models. IMPAACT4HIV focuses on increasing availability of essential commodities such as CD4 testing, CrAg, and itraconazole, and strengthening systems for equitable care in high-burden countries.
For more information about IMPAACT4HIV, please visit: Impaact4HIV
